Seeking Alpha

The FDA has approved an application by Merck (MRK +0.7%) to switch the status of the...

The FDA has approved an application by Merck (MRK +0.7%) to switch the status of the prescription patch Oxytrol, a treatment for overactive-bladder, to an over-the-counter item for women. The OTC patch, which will remain a prescription-only product for men, will be available this fall.
Comments (1)
  • Wait a minute! If it's OTC why can't men buy it?
    25 Jan 2013, 05:25 PM Reply Like
DJIA (DIA) S&P 500 (SPY)